Skip to main content
Top
Published in: Diabetologia 10/2004

01-10-2004 | For Debate

Animal models have little to teach us about Type 1 diabetes: 1. In support of this proposal

Authors: B. O. Roep, M. Atkinson

Published in: Diabetologia | Issue 10/2004

Login to get access

Excerpt

Sir Winston Churchill summed up our position in this debate when he said that “Men stumble over the truth from time to time, but most pick themselves up and hurry off as if nothing happened”. To our thinking, we (the Type 1 diabetes research community) have stumbled both in terms of the way in which data derived from animal models of Type 1 diabetes have been handled, and in the manner in which the field continues to move forward without proper acknowledgement of what has been learned. Animal models such as the non-obese diabetic (NOD) mouse and the biobreeding (BB) rat develop immune-mediated disease with features resembling Type 1 diabetes in humans [1]. Although these animal models of autoimmune diabetes have proved to be valuable tools to study certain aspects of the disease process [2], they have also led to misconceptions and erroneous extrapolations, as well as false expectations with regard to the efficacy of immunotherapy. Hence, on a number of counts, we would argue that animal models have limited value when it comes to teaching us about Type 1 diabetes in humans. …
Appendix
Available only for authorised users
Literature
1.
go back to reference Atkinson MA, Leiter EH (1999) The NOD mouse model of type 1 diabetes: as good as it gets? Nat Med 5:601–604CrossRefPubMed Atkinson MA, Leiter EH (1999) The NOD mouse model of type 1 diabetes: as good as it gets? Nat Med 5:601–604CrossRefPubMed
2.
go back to reference Leiter EH, von Herrath M (2004) Animal models have little to teach us about Type 1 diabetes: 2. In opposition to this proposal. Diabetologia 47:DOI 10.1007/s00125-004-1518-0 Leiter EH, von Herrath M (2004) Animal models have little to teach us about Type 1 diabetes: 2. In opposition to this proposal. Diabetologia 47:DOI 10.1007/s00125-004-1518-0
3.
go back to reference Mestas J, Hughes CCW (2004) Of mice and not men: differences between mouse and human immunology. J Immunol 172:2731–2738PubMed Mestas J, Hughes CCW (2004) Of mice and not men: differences between mouse and human immunology. J Immunol 172:2731–2738PubMed
4.
go back to reference Roep BO (2003) The role of T-cells in the pathogenesis of Type 1 diabetes: from cause to cure. Diabetologia 46:305–321PubMed Roep BO (2003) The role of T-cells in the pathogenesis of Type 1 diabetes: from cause to cure. Diabetologia 46:305–321PubMed
6.
go back to reference Homo-Delarche F, Drexhage HA (2004) Immune cells, pancreas development, regeneration and type 1 diabetes. Trends Immunol 25:222–227CrossRefPubMed Homo-Delarche F, Drexhage HA (2004) Immune cells, pancreas development, regeneration and type 1 diabetes. Trends Immunol 25:222–227CrossRefPubMed
7.
go back to reference Bonifacio E, Atkinson M, Eisenbarth G et al. (2001) International Workshop on Lessons From Animal Models for Human Type 1 Diabetes: identification of insulin but not glutamic acid decarboxylase or IA-2 as specific autoantigens of humoral autoimmunity in nonobese diabetic mice. Diabetes 50:2451–2458PubMed Bonifacio E, Atkinson M, Eisenbarth G et al. (2001) International Workshop on Lessons From Animal Models for Human Type 1 Diabetes: identification of insulin but not glutamic acid decarboxylase or IA-2 as specific autoantigens of humoral autoimmunity in nonobese diabetic mice. Diabetes 50:2451–2458PubMed
8.
go back to reference Bingley PJ, Bonifacio E, Gale EA (1993) Can we really predict IDDM? Diabetes 42:213–220PubMed Bingley PJ, Bonifacio E, Gale EA (1993) Can we really predict IDDM? Diabetes 42:213–220PubMed
9.
go back to reference Greeley SAW, Katsumata M, Yu LP et al. (2002) Elimination of maternally transmitted autoantibodies prevents diabetes in nonobese diabetic mice. Nat Med 8:399–402CrossRefPubMed Greeley SAW, Katsumata M, Yu LP et al. (2002) Elimination of maternally transmitted autoantibodies prevents diabetes in nonobese diabetic mice. Nat Med 8:399–402CrossRefPubMed
10.
go back to reference Herrath M von, Bach JF (2002) Juvenile autoimmune diabetes: a pathogenic role for maternal antibodies? Nat Med 8:331–333CrossRefPubMed Herrath M von, Bach JF (2002) Juvenile autoimmune diabetes: a pathogenic role for maternal antibodies? Nat Med 8:331–333CrossRefPubMed
11.
go back to reference Koczwara K, Bonifacio E, Ziegler AG (2004) Transmission of maternal islet antibodies and risk of autoimmune diabetes in offspring of mothers with type 1 diabetes. Diabetes 53:1–4PubMed Koczwara K, Bonifacio E, Ziegler AG (2004) Transmission of maternal islet antibodies and risk of autoimmune diabetes in offspring of mothers with type 1 diabetes. Diabetes 53:1–4PubMed
12.
go back to reference Serreze DV, Chapman HD, Varnum DS et al. (1996) B lymphocytes are essential for the initiation of T cell-mediated autoimmune diabetes: analysis of a new “speed congenic” stock of NOD.Ig mu null mice. J Exp Med 184:2049–2053CrossRefPubMed Serreze DV, Chapman HD, Varnum DS et al. (1996) B lymphocytes are essential for the initiation of T cell-mediated autoimmune diabetes: analysis of a new “speed congenic” stock of NOD.Ig mu null mice. J Exp Med 184:2049–2053CrossRefPubMed
13.
go back to reference Martin S, Wolf-Eichbaum D, Duinkerken G et al. (2001) Development of type 1 diabetes despite severe hereditary B-lymphocyte deficiency. N Engl J Med 345:1036–1040CrossRefPubMed Martin S, Wolf-Eichbaum D, Duinkerken G et al. (2001) Development of type 1 diabetes despite severe hereditary B-lymphocyte deficiency. N Engl J Med 345:1036–1040CrossRefPubMed
14.
go back to reference Pedotti R, Sanna M, Tsai M et al. (2003) Severe anaphylactic reactions to glutamic acid decarboxylase (GAD) self peptides in NOD mice that spontaneously develop autoimmune type 1 diabetes mellitus. BMC Immunol 4:2CrossRefPubMed Pedotti R, Sanna M, Tsai M et al. (2003) Severe anaphylactic reactions to glutamic acid decarboxylase (GAD) self peptides in NOD mice that spontaneously develop autoimmune type 1 diabetes mellitus. BMC Immunol 4:2CrossRefPubMed
15.
go back to reference Pozzilli P, Signore A, Williams AJK, Beales PE (1993) Nod mouse colonies around the world—recent facts and figures. Immunol Today 14:193–196CrossRefPubMed Pozzilli P, Signore A, Williams AJK, Beales PE (1993) Nod mouse colonies around the world—recent facts and figures. Immunol Today 14:193–196CrossRefPubMed
16.
go back to reference Endl J, Otto H, Jung G et al. (1997) Identification of naturally processed T cell epitopes from glutamic acid decarboxylase presented in the context of HLA-DR alleles by T lymphocytes of recent onset IDDM patients. J Clin Invest 99:2405–2415PubMed Endl J, Otto H, Jung G et al. (1997) Identification of naturally processed T cell epitopes from glutamic acid decarboxylase presented in the context of HLA-DR alleles by T lymphocytes of recent onset IDDM patients. J Clin Invest 99:2405–2415PubMed
17.
go back to reference Wicker LS, Chen SL, Nepom GT et al. (1996) Naturally processed T cell epitopes from human glutamic acid decarboxylase identified using mice transgenic for the type 1 diabetes-associated human MHC class II allele, DRB1*0401. J Clin Invest 98:2597–2603PubMed Wicker LS, Chen SL, Nepom GT et al. (1996) Naturally processed T cell epitopes from human glutamic acid decarboxylase identified using mice transgenic for the type 1 diabetes-associated human MHC class II allele, DRB1*0401. J Clin Invest 98:2597–2603PubMed
Metadata
Title
Animal models have little to teach us about Type 1 diabetes: 1. In support of this proposal
Authors
B. O. Roep
M. Atkinson
Publication date
01-10-2004
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 10/2004
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-004-1517-1

Other articles of this Issue 10/2004

Diabetologia 10/2004 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.